Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
55°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Agenus Inc
(NQ:
AGEN
)
3.905
-0.025 (-0.64%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Agenus Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Gold Moves Higher; Auddia Shares Surge
April 08, 2024
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 0.1% on Monday. The Dow traded up 0.04% to 38,919.32 while the NASDAQ rose 0.11% to 16,266.07. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 08, 2024
Shares of Agenus Inc. (NASDAQ: AGEN) fell sharply during Monday’s session. Agenus disclosed a 1-for-20 reverse stock split of common stock. Agenus Inc. (NASDAQ: AGEN) declined 17% to $0.4181 on...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 08, 2024
Via
Benzinga
Earnings Preview For Agenus
March 13, 2024
Via
Benzinga
Crude Oil Moves Lower; Perion Network Shares Tumble
April 08, 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 50 points on Monday. The Dow traded up 0.21% to 38,983.94 while the NASDAQ rose 0.39% to 16,311.32. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 08, 2024
It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Down 75%. Is Agenus Stock a Buy on the Dip?
April 08, 2024
Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.
Via
The Motley Fool
RADCOM, Lotus Technology And 3 Stocks To Watch Heading Into Monday
April 08, 2024
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Agenus Announces Reverse Stock Split of Common Stock
April 05, 2024
From
Agenus Inc.
Via
Business Wire
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
April 03, 2024
These stocks could rocket higher, but they also present significant risks.
Via
The Motley Fool
3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million
March 24, 2024
If you want the chance at possible absurd returns, then consider gambling on these stocks to turn $1,000 into $1 million.
Via
InvestorPlace
Agenus (AGEN) Q4 2023 Earnings Call Transcript
March 14, 2024
AGEN earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Agenus Reports Fourth Quarter and Full Year 2023 Results
March 14, 2024
From
Agenus Inc.
Via
Business Wire
Earnings Scheduled For March 14, 2024
March 14, 2024
Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.
Via
Benzinga
Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
March 06, 2024
From
Agenus Inc.
Via
Business Wire
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2024
From
Agenus Inc.
Via
Business Wire
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
February 29, 2024
From
Agenus Inc.
Via
Business Wire
Agenus to Participate in Leerink Partners Global Biopharma Conference
February 26, 2024
From
Agenus Inc.
Via
Business Wire
Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today
February 15, 2024
The company hopes to engineer a 1-for-20 reverse stock split.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
February 15, 2024
Via
Benzinga
7 Analyst-Backed Stocks With Promising 10-Bagger Potential
February 01, 2024
Although true 10-baggers are by nature extremely difficult to come by, these analyst-backed stocks may offer a decent shot.
Via
InvestorPlace
Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 31, 2024
From
Agenus Inc.
Via
Business Wire
3 Biotech Stocks with Potential for Major Medical Breakthroughs in 2024
January 26, 2024
There are several potential biotech breakthroughs likely to occur in 2024, and these three biotech stocks could see substantial gains
Via
InvestorPlace
Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
January 22, 2024
From
Agenus Inc.
Via
Business Wire
Why LQR House Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
January 16, 2024
Shares of LQR House Inc. (NASDAQ: LQR) rose sharply in pre-market trading. Borg's investor group has acquired a 20% stake in LQR House. LQR House shares jumped 16.1% to $4.25 in pre-market trading Here...
Via
Benzinga
Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 05, 2024
From
Agenus Inc.
Via
Business Wire
Agenus to Participate in B. Riley Healthcare Conference
January 04, 2024
From
Agenus Inc.
Via
Business Wire
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
December 24, 2023
These two biotech stocks could be poised for a trend reversal.
Via
The Motley Fool
Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024
December 20, 2023
From
Agenus Inc.
Via
Business Wire
Agenus to Receive $25 Million Milestone Payment from Bristol Myers Squibb for TIGIT-CD96 Bispecific Program
December 11, 2023
From
Agenus Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.